
Movement Disorders Publications
NYU Langone’s Kellar Family Division of Movement Disorders faculty publish frequently in prestigious, peer-reviewed journals. Here is a selection of their recent publications.
Pepinemab: a SEMA4D antagonist for treatment of Huntington's and other neurodegenerative diseases
Expert opinion on investigational drugs. 2025 Mar 06; 1-11
Toward a biological definition of neuronal and glial synucleinopathies
Nature medicine. 2025 Feb ; 31:396-408
The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology
Parkinsonism & related disorders. 2025 Feb ; 131:107256
Efficacy and Safety of Sodium Oxybate in Isolated Focal Laryngeal Dystonia: A Phase IIb Double-Blind Placebo-Controlled Cross-Over Randomized Clinical Trial
Annals of neurology. 2025 Feb ; 97:329-343
Association between the Amplification Parameters of the α-Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease
Movement disorders. 2025 Feb ; 40:305-314
Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy
Acta neuropathologica. 2024 Dec 09; 148:80
IAPRD new consensus classification of myoclonus
Parkinsonism & related disorders. 2024 Dec 04; 107216
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis
Nature reviews. Neurology. 2024 Dec ; 20:724-737